• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶并苯并噻唑酮衍生物 HeE1-17Y 对包膜 RNA 病毒的病毒杀灭活性。

Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses.

机构信息

Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy.

Biophysics Institute, CNR-IBF, Via Celoria 26, 20133 Milano, Italy.

出版信息

Viruses. 2022 May 27;14(6):1157. doi: 10.3390/v14061157.

DOI:10.3390/v14061157
PMID:35746629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9228864/
Abstract

Pyridobenzothiazolone derivatives are a promising class of broad-spectrum antivirals. However, the mode of action of these compounds remains poorly understood. The HeE1-17Y derivative has already been shown to be a potent compound against a variety of flaviviruses of global relevance. In this work, the mode of action of HeE1-17Y has been studied for West Nile virus taking advantage of reporter replication particles (RRPs). Viral infectivity was drastically reduced by incubating the compound with the virus before infection, thus suggesting a direct interaction with the viral particles. Indeed, RRPs incubated with the inhibitor appeared to be severely compromised in electron microscopy analysis. HeE1-17Y is active against other enveloped viruses, including SARS-CoV-2, but not against two non-enveloped viruses, suggesting a virucidal mechanism that involves the alteration of the viral membrane.

摘要

吡啶并苯并噻唑酮衍生物是一类有前途的广谱抗病毒药物。然而,这些化合物的作用模式仍知之甚少。HeE1-17Y 衍生物已被证明是一种针对多种具有全球相关性的黄病毒的有效化合物。在这项工作中,利用报告复制颗粒 (RRPs) 研究了 HeE1-17Y 对西尼罗河病毒的作用模式。在感染前用化合物孵育病毒会大大降低病毒的感染力,因此表明它与病毒颗粒直接相互作用。事实上,用抑制剂孵育的 RRPs 在电子显微镜分析中似乎受到严重损害。HeE1-17Y 对包括 SARS-CoV-2 在内的其他包膜病毒有效,但对两种非包膜病毒无效,这表明其具有病毒杀伤机制,涉及病毒膜的改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/dceab707a271/viruses-14-01157-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/1e7350fb4f12/viruses-14-01157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/8c93583410bb/viruses-14-01157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/5185d7e79c3d/viruses-14-01157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/a4420e663d17/viruses-14-01157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/87c7c94af927/viruses-14-01157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/dceab707a271/viruses-14-01157-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/1e7350fb4f12/viruses-14-01157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/8c93583410bb/viruses-14-01157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/5185d7e79c3d/viruses-14-01157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/a4420e663d17/viruses-14-01157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/87c7c94af927/viruses-14-01157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1035/9228864/dceab707a271/viruses-14-01157-g006.jpg

相似文献

1
Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses.吡啶并苯并噻唑酮衍生物 HeE1-17Y 对包膜 RNA 病毒的病毒杀灭活性。
Viruses. 2022 May 27;14(6):1157. doi: 10.3390/v14061157.
2
A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.一种光激活的天然产物,对包膜病毒具有广泛的抗病毒活性,包括高致病性冠状病毒。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0158121. doi: 10.1128/AAC.01581-21. Epub 2021 Nov 22.
3
Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses.反式-δ-viniferin 衍生物对包膜病毒的抗病毒特性。
Biomed Pharmacother. 2023 Jul;163:114825. doi: 10.1016/j.biopha.2023.114825. Epub 2023 May 4.
4
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2.以系统为导向的多目标 2,6-二氨基嘌呤衍生物的优化:易于获得的广谱抗黄病毒、流感病毒和 SARS-CoV-2 的抗病毒药物。
Eur J Med Chem. 2021 Nov 15;224:113683. doi: 10.1016/j.ejmech.2021.113683. Epub 2021 Jul 5.
5
Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.广谱抗病毒化合物扰乱寨卡病毒子代释放,挽救脑类器官中的病毒诱导毒性。
Viruses. 2020 Dec 29;13(1):37. doi: 10.3390/v13010037.
6
Triaryl pyrazoline compound inhibits flavivirus RNA replication.三芳基吡唑啉化合物抑制黄病毒RNA复制。
Antimicrob Agents Chemother. 2006 Apr;50(4):1320-9. doi: 10.1128/AAC.50.4.1320-1329.2006.
7
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.新型、强效二氢乳清酸脱氢酶(DHODH)抑制剂是广谱抗 RNA 病毒药物,可针对包括新型冠状病毒 SARS-CoV-2 在内的多种 RNA 病毒。
Protein Cell. 2020 Oct;11(10):723-739. doi: 10.1007/s13238-020-00768-w. Epub 2020 Aug 4.
8
A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses.一种衔接蛋白抑制剂可阻断 SARS-CoV-2 及其一系列 RNA 病毒进入内体。
Viruses. 2022 Oct 6;14(10):2202. doi: 10.3390/v14102202.
9
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.广谱抗黄病毒吡啶并苯并噻唑酮导致感染性病毒颗粒减少。
Antiviral Res. 2019 Jul;167:6-12. doi: 10.1016/j.antiviral.2019.03.004. Epub 2019 Mar 6.
10
Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.原卟啉的广谱抗病毒药物可抑制高致病性新兴病毒的进入。
Bioorg Chem. 2021 Feb;107:104619. doi: 10.1016/j.bioorg.2020.104619. Epub 2021 Jan 5.

引用本文的文献

1
Broad-Spectrum Antiviral Activity of Pyridobenzothiazolone Analogues Against Respiratory Viruses.吡啶并苯并噻唑酮类似物对呼吸道病毒的广谱抗病毒活性
Viruses. 2025 Jun 24;17(7):890. doi: 10.3390/v17070890.
2
New Pyridobenothiazolone Derivatives Display Nanomolar Pan-Serotype Anti-Dengue Virus Activity.新型吡啶苯并噻唑酮衍生物展现出纳摩尔级的全血清型抗登革病毒活性。
ChemMedChem. 2025 Jul 1;20(13):e202500163. doi: 10.1002/cmdc.202500163. Epub 2025 Apr 21.
3
Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr.

本文引用的文献

1
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.瑞德西韦早期治疗可降低门诊患者重症 COVID-19 进展风险
N Engl J Med. 2022 Jan 27;386(4):305-315. doi: 10.1056/NEJMoa2116846. Epub 2021 Dec 22.
2
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
3
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets.瑞德西韦前药 GS-441524 经口给药对雪貂体内 SARS-CoV-2 有效。
非核苷类抑制剂HeE1-2Tyr抑制新型冠状病毒聚合酶的结构基础
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2419854122. doi: 10.1073/pnas.2419854122. Epub 2025 Mar 4.
4
Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner.可定制设计的多聚体以一种对变体不敏感的方式中和 SARS-CoV-2。
Front Immunol. 2023 Aug 10;14:1226880. doi: 10.3389/fimmu.2023.1226880. eCollection 2023.
5
Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova.国药集团(BBIBP-CorV)疫苗接种者及摩尔多瓦共和国新冠康复者血清中抗体反应的特征分析
Vaccines (Basel). 2023 Mar 13;11(3):637. doi: 10.3390/vaccines11030637.
Nat Commun. 2021 Nov 5;12(1):6415. doi: 10.1038/s41467-021-26760-4.
4
Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review.新出现和再次出现的媒介传播传染病及其控制面临的挑战:综述
Front Public Health. 2021 Oct 5;9:715759. doi: 10.3389/fpubh.2021.715759. eCollection 2021.
5
Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication.非核苷酸依赖的 RNA 依赖性 RNA 聚合酶抑制剂,可阻断 SARS-CoV-2 复制。
Viruses. 2021 Aug 11;13(8):1585. doi: 10.3390/v13081585.
6
The race for antiviral drugs to beat COVID - and the next pandemic.研发抗病毒药物以战胜新冠疫情及应对下一场大流行的竞赛。
Nature. 2021 Apr;592(7854):340-343. doi: 10.1038/d41586-021-00958-4.
7
Antiviral drug discovery: preparing for the next pandemic.抗病毒药物的发现:为下一次大流行做准备。
Chem Soc Rev. 2021 Mar 21;50(6):3647-3655. doi: 10.1039/d0cs01118e. Epub 2021 Feb 1.
8
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents.可持续的、三组分、一锅法制备活性抗黄病毒药物。
Eur J Med Chem. 2021 Jan 15;210:112992. doi: 10.1016/j.ejmech.2020.112992. Epub 2020 Nov 4.
9
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
10
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.广谱黄病毒抑制剂:药物化学视角
ChemMedChem. 2020 Dec 15;15(24):2391-2419. doi: 10.1002/cmdc.202000464. Epub 2020 Oct 22.